Gå direkte til indholdet

Kritisk syge og intensiv behandling

Anæmibehandling

Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (åbner nyt vindue)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Kilde‎: Crit Care Med 2009;37(4):1299-307.

Indekseret‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (åbner nyt vindue)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (åbner nyt vindue)

Ball AM, Winstead PS.

Kilde‎: Pharmacotherapy 2008;28(11):1383-90.

Indekseret‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (åbner nyt vindue)

Reducing postburn injury anemia in a Jehovah's Witness patient. (åbner nyt vindue)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Kilde‎: J Burn Care Res 2014;35(4):e258-61.

Indekseret‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (åbner nyt vindue)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (åbner nyt vindue)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Kilde‎: Clin Ther 2008;30(12):2324-34.

Indekseret‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (åbner nyt vindue)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (åbner nyt vindue)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Kilde‎: Transplant Proc 2015;47(8):2548-51.

Indekseret‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (åbner nyt vindue)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (åbner nyt vindue)

Charles A, Purtill M, Napolitano LM.

Kilde‎: Anaesth Intensive Care 2006;34(6):793-6.

Indekseret‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (åbner nyt vindue)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (åbner nyt vindue)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Kilde‎: Crit Care Med 1999;27(11):2346-50.

Indekseret‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (åbner nyt vindue)

Erythropoietin for critically ill trauma patients: a missed opportunity? (åbner nyt vindue)

Corwin HL, Napolitano LM

Kilde‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indekseret‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (åbner nyt vindue)

Postoperative management of severe acute anemia in a Jehovah's Witness. (åbner nyt vindue)

de Araújo Azi LM, Lopes FM, Garcia LV

Kilde‎: Transfusion 2014;54(4):1153-7.

Indekseret‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (åbner nyt vindue)

Restrictive transfusion in geriatric trauma patients. (åbner nyt vindue)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Kilde‎: Am Surg 2016;82(1):85-8.

Indekseret‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (åbner nyt vindue)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (åbner nyt vindue)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Kilde‎: J Trauma 1998;44(2):361-7.

Indekseret‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (åbner nyt vindue)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (åbner nyt vindue)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Kilde‎: Crit Care 2005;9(5):R508-15.

Indekseret‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (åbner nyt vindue)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (åbner nyt vindue)

Lindholm J, Palmér K, Frenckner B.

Kilde‎: Perfusion 2012;27(4):332-4.

Indekseret‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (åbner nyt vindue)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (åbner nyt vindue)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Kilde‎: Am Surg 2010;76(9):951-6.

Indekseret‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (åbner nyt vindue)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (åbner nyt vindue)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Kilde‎: Intensive Care Med 2013;39(11):1896-908.

Indekseret‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (åbner nyt vindue)

Transfusion-free treatment strategies for acute anemia in critical care. (åbner nyt vindue)

Morgan CA, Byul Sarah S, Forest CP.

Kilde‎: JAAPA 2016;29(8):38-44.

Indekseret‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (åbner nyt vindue)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (åbner nyt vindue)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Kilde‎: J Trauma 2008;65(2):285-97.

Indekseret‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (åbner nyt vindue)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (åbner nyt vindue)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Kilde‎: J Trauma 2009;67(1):121-4.

Indekseret‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (åbner nyt vindue)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (åbner nyt vindue)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Kilde‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indekseret‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (åbner nyt vindue)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (åbner nyt vindue)

Posluszny JA Jr, Napolitano LM.

Kilde‎: Transfusion 2014;54(12):3026-34.

Indekseret‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (åbner nyt vindue)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (åbner nyt vindue)

Price S, Pepper JR, Jaggar SI.

Kilde‎: Anesth Analg 2005;101(2):325-7.

Indekseret‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (åbner nyt vindue)

Erythropoietin response is blunted in critically ill patients. (åbner nyt vindue)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Kilde‎: Intensive Care Med 1997;23(2):159-62.

Indekseret‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (åbner nyt vindue)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (åbner nyt vindue)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Kilde‎: Br J Anaesth 2005;94(4):442-4.

Indekseret‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (åbner nyt vindue)

Management of anemia in patients who decline blood transfusion. (åbner nyt vindue)

Shander A, Goodnough LT

Kilde‎: Am J Hematol 2018;93(9):1183-91.

Indekseret‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (åbner nyt vindue)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (åbner nyt vindue)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Kilde‎: Arch Surg 2012;147(3):251-5.

Indekseret‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (åbner nyt vindue)

Intravenous iron following cardiac surgery does not increase the infection rate. (åbner nyt vindue)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Kilde‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indekseret‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (åbner nyt vindue)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (åbner nyt vindue)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Kilde‎: Crit Care 2015;19:49.

Indekseret‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (åbner nyt vindue)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (åbner nyt vindue)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Kilde‎: Crit Care Med 2024;52(4):618-25.

Indekseret‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (åbner nyt vindue)